Attached files

file filename
EX-31.2 - EXHIBIT 31.2 - INTERMOLECULAR INCex312_cfox10k.htm
EX-32.2 - EXHIBIT 32.2 - INTERMOLECULAR INCex322_cfox10k.htm
EX-31.1 - EXHIBIT 31.1 - INTERMOLECULAR INCex311_ceox10k.htm
EX-10.39 - EXHIBIT 10.39 - INTERMOLECULAR INCex1039_griffinxagreement.htm
EX-10.40 - EXHIBIT 10.40 - INTERMOLECULAR INCex1040_separationagreement.htm
EX-10.42 - EXHIBIT 10.42 - INTERMOLECULAR INCex1042_separationagreement.htm
EX-10.41 - EXHIBIT 10.41 - INTERMOLECULAR INCex1041_separationagreement.htm
EX-10.37 - EXHIBIT 10.37 - INTERMOLECULAR INCex1037_guardianxamendment4.htm
EX-10.38 - EXHIBIT 10.38 - INTERMOLECULAR INCex1038_mcwilliamsxagreement.htm
EXCEL - IDEA: XBRL DOCUMENT - INTERMOLECULAR INCFinancial_Report.xls
10-K - 10-K - INTERMOLECULAR INCa10k-20141231.htm
EX-32.1 - EXHIBIT 32.1 - INTERMOLECULAR INCex321_ceox10k.htm


Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
The Board of Directors
Intermolecular, Inc.:
We consent to the incorporation by reference in the registration statement (No. 333-178154, 333-180169, 333-187017 and 333-194464) on Form S-8 of Intermolecular, Inc. of our reports dated February 27, 2015, with respect to the consolidated balance sheets of Intermolecular, Inc. and subsidiaries as of December 31, 2014 and 2013, and the related consolidated statements of operations, comprehensive loss, stockholders’ equity, and cash flows for each of the years in the three-year period ended December 31, 2014, and the effectiveness of internal control over financial reporting as of December 31, 2014, which reports appear in the December 31, 2014 annual report on Form 10-K of Intermolecular, Inc.

/s/ KPMG LLP
Santa Clara, California
February 27, 2015